Home
DERM
DERM News

Latest Journey Medical Corporation (DERM) News on October 21, 2025

Journey Medical Corporation to Participate in October 2025 Investor Conferences

GlobeNewswire

13 days ago

Journey Medical Corporation to Participate in October 2025 Investor Conferences

MT Newswires

3 months ago

Journey Medical's Emrosi Coverage Jumps to 65% of U.S. Commercial Lives

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™

GlobeNewswire

3 months ago

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™

MT Newswires

4 months ago

Journey Medical to Join Russell 2000, Russell 3000 Indexes

Journey Medical to Join Russell 2000® and Russell 3000® Indexes

GlobeNewswire

4 months ago

Journey Medical to Join Russell 2000® and Russell 3000® Indexes

Journey Medical announces data analysis from Phase 3 trials of Emrosi

TipRanks

4 months ago

Journey Medical announces data analysis from Phase 3 trials of Emrosi

Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference

GlobeNewswire

4 months ago

Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference

Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV

GlobeNewswire

4 months ago

Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV

Will Tesla have to play catch up to Waymo's robotaxis?

Yahoo Finance Video

5 months ago

Will Tesla have to play catch up to Waymo's robotaxis?

Why Scott Bessent wants to make it easier for banks to own Treasurys

Yahoo Finance

5 months ago

Why Scott Bessent wants to make it easier for banks to own Treasurys

Statement by Minister Guilbeault on Portuguese Heritage Month

CNW Group

5 months ago

Statement by Minister Guilbeault on Portuguese Heritage Month

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population

PR Newswire

5 months ago

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population

GlobeNewswire

5 months ago

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry

GlobeNewswire

5 months ago

EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry

Man Utd sign Brazil forward Cunha from Wolves

AFP

5 months ago

Man Utd sign Brazil forward Cunha from Wolves

‘All the crypto cowboys are gone’: Kevin O’Leary says the sector is safe now and is backing stablecoins

Moneywise

5 months ago

‘All the crypto cowboys are gone’: Kevin O’Leary says the sector is safe now and is backing stablecoins

GuruFocus.com

5 months ago

Journey Medical Corp (DERM) Q1 2025 Earnings Call Highlights: Amrosi Launch Boosts Margins ...

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

GlobeNewswire

5 months ago

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates

Zacks

5 months ago

Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

GlobeNewswire

5 months ago

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

What To Expect From Journey Medical Corp (DERM) Q1 2025 Earnings

GuruFocus.com

5 months ago

What To Expect From Journey Medical Corp (DERM) Q1 2025 Earnings

The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates

Zacks

5 months ago

The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

GlobeNewswire

5 months ago

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength?

Zacks

6 months ago

Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength?

Why Journey Medical Corporation (DERM) is Surging in 2025

Insider Monkey

6 months ago

Why Journey Medical Corporation (DERM) is Surging in 2025

Journey Medical (DERM) Moves 16.8% Higher: Will This Strength Last?

Zacks

6 months ago

Journey Medical (DERM) Moves 16.8% Higher: Will This Strength Last?

Is Journey Medical Corporation (DERM) a Cheap Hot Stock to Buy Right Now?

Insider Monkey

6 months ago

Is Journey Medical Corporation (DERM) a Cheap Hot Stock to Buy Right Now?

Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains?

Zacks

6 months ago

Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains?

MT Newswires

7 months ago

Journey Medical Promotes Ramsey Alloush to COO

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

GlobeNewswire

7 months ago

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

Journey Medical Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

7 months ago

Journey Medical Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Thomson Reuters StreetEvents

7 months ago

Q4 2024 Journey Medical Corp Earnings Call

GuruFocus.com

7 months ago

Journey Medical Corp (DERM) Q4 2024 Earnings Call Highlights: Strategic Launch of Emrosi and ...

Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates

Zacks

7 months ago

Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

7 months ago

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corp (DERM) Q4 2024 Earnings Report Preview: What To Expect

GuruFocus.com

7 months ago

Journey Medical Corp (DERM) Q4 2024 Earnings Report Preview: What To Expect

Journey Medical launches Emrosi for the treatment of rosacea

TipRanks

7 months ago

Journey Medical launches Emrosi for the treatment of rosacea

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

GlobeNewswire

7 months ago

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

GlobeNewswire

7 months ago

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

GlobeNewswire

7 months ago

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea

GlobeNewswire

8 months ago

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea

Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida

GlobeNewswire

8 months ago

Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida

Journey Medical Corporation (DERM): A Bull Case Theory

Insider Monkey

8 months ago

Journey Medical Corporation (DERM): A Bull Case Theory

Journey Medical Corporation's (NASDAQ:DERM) biggest owners are public companies who got richer after stock soared 32% last week

Simply Wall St.

9 months ago

Journey Medical Corporation's (NASDAQ:DERM) biggest owners are public companies who got richer after stock soared 32% last week

Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM)

Insider Monkey

9 months ago

Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM)

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

GlobeNewswire

9 months ago

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Despite Journey Medical's Pullback, Insiders Still Gained US$118k

Simply Wall St.

a year ago

Despite Journey Medical's Pullback, Insiders Still Gained US$118k

Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates

Zacks

a year ago

Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

a year ago

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

FDA approves Journey Medical’s rosacea treatment Emrosi

Pharmaceutical Technology

a year ago

FDA approves Journey Medical’s rosacea treatment Emrosi

MT Newswires

a year ago

Journey Medical Gets FDA Approval for Rosacea Treatment

Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock?

Zacks

a year ago

Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock?

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

GlobeNewswire

a year ago

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

GlobeNewswire

a year ago

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

ACCESSWIRE

a year ago

SWK Holdings Provides Portfolio Update

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

GlobeNewswire

a year ago

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Can Journey Medical Corporation (NASDAQ:DERM) Improve Its Returns?

Simply Wall St.

a year ago

Can Journey Medical Corporation (NASDAQ:DERM) Improve Its Returns?

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

GlobeNewswire

a year ago

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

a year ago

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Journey Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a year ago

Journey Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Journey Medical Corporation (NASDAQ:DERM) Just Reported And Analysts Have Been Lifting Their Price Targets

Simply Wall St.

a year ago

Journey Medical Corporation (NASDAQ:DERM) Just Reported And Analysts Have Been Lifting Their Price Targets

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

a year ago

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates

Zacks

a year ago

Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

a year ago

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Oncternal Therapeutics (ONCT) Reports Q2 Loss, Tops Revenue Estimates

Zacks

a year ago

Oncternal Therapeutics (ONCT) Reports Q2 Loss, Tops Revenue Estimates

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

GlobeNewswire

a year ago

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

ACCESSWIRE

a year ago

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

4D Molecular Therapeutics (FDMT) Moves 11.1% Higher: Will This Strength Last?

Zacks

a year ago

4D Molecular Therapeutics (FDMT) Moves 11.1% Higher: Will This Strength Last?

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

GlobeNewswire

a year ago

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

Public companies are Journey Medical Corporation's (NASDAQ:DERM) biggest owners and were rewarded after market cap rose by US$26m last week

Simply Wall St.

a year ago

Public companies are Journey Medical Corporation's (NASDAQ:DERM) biggest owners and were rewarded after market cap rose by US$26m last week

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

GlobeNewswire

a year ago

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

GuruFocus.com

a year ago

Journey Medical Corp (DERM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Growth ...

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

a year ago

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

GlobeNewswire

a year ago

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

GlobeNewswire

a year ago

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

ACCESSWIRE

a year ago

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

GlobeNewswire

a year ago

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

Director Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM)

GuruFocus.com

2 years ago

Director Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM)

Journey Medical Full Year 2023 Earnings: EPS Misses Expectations

Simply Wall St.

2 years ago

Journey Medical Full Year 2023 Earnings: EPS Misses Expectations

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Journey Medical Corp Earnings Call

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire

2 years ago

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA

Zacks

2 years ago

Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

GlobeNewswire

2 years ago

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

GlobeNewswire

2 years ago

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

GlobeNewswire

2 years ago

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

GlobeNewswire

2 years ago

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

Journey Medical Insiders Up US$187k On US$520.8k Investment

Simply Wall St.

2 years ago

Journey Medical Insiders Up US$187k On US$520.8k Investment

Journey Medical (DERM) to Report Q4 Earnings: What's in the Cards?

Zacks

2 years ago

Journey Medical (DERM) to Report Q4 Earnings: What's in the Cards?

Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B

Zacks

2 years ago

Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B

Community West Bancshares Reports Full Year Earnings and Declares Quarterly Cash Dividend of $0.08 Per Common Share

GlobeNewswire

2 years ago

Community West Bancshares Reports Full Year Earnings and Declares Quarterly Cash Dividend of $0.08 Per Common Share

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.

PR Newswire

2 years ago

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.

Bay Commercial Bank (BCML) Lags Q4 Earnings Estimates

Zacks

2 years ago

Bay Commercial Bank (BCML) Lags Q4 Earnings Estimates

West Bancorp Inc (WTBA) Reports Decline in Annual Net Income Amid Margin Challenges

GuruFocus.com

2 years ago

West Bancorp Inc (WTBA) Reports Decline in Annual Net Income Amid Margin Challenges

NaaS Technology's Full Portfolio of Charging Pile Products Obtained CE Certification from the European Union

PR Newswire

2 years ago

NaaS Technology's Full Portfolio of Charging Pile Products Obtained CE Certification from the European Union

American Superconductor (AMSC) Q3 Earnings and Revenues Top Estimates

Zacks

2 years ago

American Superconductor (AMSC) Q3 Earnings and Revenues Top Estimates

Standard Lithium Advances South West Arkansas Project: Definitive Feasibility Study and Front-End Engineering Design Firm Chosen

GlobeNewswire

2 years ago

Standard Lithium Advances South West Arkansas Project: Definitive Feasibility Study and Front-End Engineering Design Firm Chosen

LivePerson Adopts Tax Benefits Preservation Plan To Protect Valuable Tax Assets

PR Newswire

2 years ago

LivePerson Adopts Tax Benefits Preservation Plan To Protect Valuable Tax Assets

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01

GlobeNewswire

2 years ago

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01

Genetron Health to Hold Extraordinary General Meeting of Shareholders

GlobeNewswire

2 years ago

Genetron Health to Hold Extraordinary General Meeting of Shareholders

FAT Brands Makes West Coast Debut of Co-Branded Johnny Rockets and Hurricane Wings

GlobeNewswire

2 years ago

FAT Brands Makes West Coast Debut of Co-Branded Johnny Rockets and Hurricane Wings

Share on Social Networks: